相关实验视频

Updated: Jan 15, 2026

Synthesis of an In vivo MRI-detectable Apoptosis Probe

Synthesis of an In vivo MRI-detectable Apoptosis Probe

Published on: July 31, 2012

一个分子探针用于检测MRI中的胆化酶活性

Sajal Sen¹, Miranda Dawson¹, Gregory D Thiabaud¹

¹Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.

Proceedings of the National Academy of Sciences of the United States of America

|October 8, 2025

概括

研究人员开发了ChERT,这是一个成像探针,用于使用MRI非侵入性检测胆酶 (ChE) 活动. 这种探测器在富含ChE的部位上积累,使大脑和外围的胆固醇系统可视化.

科学领域:

神经科学是一个神经科学.
生物医学成像技术生物医学成像技术
分子生物学分子生物学

背景情况:

胆酶 (ChE) 酶对于神经传递至关重要,调节乙胆的活性.
对ChE活动的非侵入性监测对于了解胆固醇系统和相关疾病至关重要.
目前用于ChE检测的方法缺乏非侵入性,全身适用性.

研究的目的:

利用磁共振成像 (MRI) 开发一种新的成像探针,用于非侵入性检测胆酶活性.
评估探测器在大脑和外围组织中可视化丰富ChE区域的能力.
为了确认探针与胆化酶活性相关的特异性和定位.

主要方法:

开发一种新型成像探头ChERT,该探头旨在进行酶处理和降低溶解度,以便在ChE地点积累.
在动物模型中,通过广场大脑和腹部输送给ChERT.
检测ChERT诱导的MRI对比度变化,并使用光显微镜和酶抑制剂进行确认.

主要成果:

切尔特成功地产生了可检测的MRI对比变化,这些变化发生在已知高胆酶丰富的脑部区域.
选择性酶抑制剂抑制了ChERT积累和MRI信号变化,证实了探针的特异性.
在腹部分娩后,ChERT有效地标记了外围组织,特别是肠道的预期ChE表达区域.
光显微镜在更高分辨率下证实了ChERT与ChE在大脑和外围组织中的同位化.

结论:

开发的ChERT探头可以通过MRI进行胆酶活性的非侵入性检测和可视化.
切尔特在评估全身,包括大脑和外围的胆固醇表现型方面表现出多功能性.
这种成像剂为基础研究和与胆固醇系统相关的临床应用提供了有前途的工具.

关键词:

脑子脑子脑子大脑对比剂是一种对比剂.分子成像分子成像技术神经化学神经化学周围神经系统周围神经系统

更多相关视频

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

The Use of Magnetic Resonance Spectroscopy as a Tool for the Measurement of Bi-hemispheric Transcranial Electric Stimulation Effects on Primary Motor Cortex Metabolism

The Use of Magnetic Resonance Spectroscopy as a Tool for the Measurement of Bi-hemispheric Transcranial Electric Stimulation Effects on Primary Motor Cortex Metabolism

Published on: November 19, 2014

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...

Labeling DNA Probes

Labeling DNA Probes

DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...